Form 4: Cellebrite CFO Sells Shares for Tax Obligations
Statement of Changes in Beneficial Ownership
Cellebrite's Chief Financial Officer, David Barter, disposed of 41,734 ordinary shares to cover tax obligations related to vested restricted stock units.
Summary
- David Barter, Chief Financial Officer of Cellebrite DI Ltd., sold 41,734 ordinary shares on July 8, 2026.
- The sale was to satisfy tax obligations arising from the vesting of restricted stock units (RSUs) granted on July 7, 2025.
- The shares were sold at a weighted average price of $16.3756, with individual transactions ranging from $16.21 to $16.62.
- Following the transaction, Barter beneficially owns 334,219 ordinary shares directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a routine tax settlement by an executive and does not provide new financial or strategic information about the company.
Negatives
- The disposal of shares by the CFO could be perceived negatively by the market, although it is for tax settlement purposes.
Risks
- The disposition of shares by a key executive might be interpreted as a lack of confidence, despite being for tax settlement.
- The weighted average sale price indicates a narrow range, suggesting consistent market pricing at the time of sale.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports a past transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The sale of shares by a CFO to cover tax obligations is a common occurrence tied to equity compensation vesting and does not inherently signal a change in the company's operational or strategic outlook.
Stakeholder Impact
- Shareholders: The sale of shares by the CFO, while for tax purposes, might lead to short-term market perception shifts, though the underlying beneficial ownership remains significant.
Key Dates
| Date | Description |
|---|---|
| 07/07/2025 | Date restricted stock units (RSUs) were granted. |
| 07/08/2026 | Date of transaction (disposal of shares). |
| 07/09/2026 | Date of signature on the filing. |
Keywords
Form 4, Cellebrite DI Ltd., CLBT, David Barter, Chief Financial Officer, Share Disposal, Restricted Stock Units, Tax Obligations, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.